INPLASY2025100078

Anti-CD3/CD20 bispecific antibodies as salvage therapy after CAR-T failure in relapsed/refractory large B-cell lymphoma: A systematic review and meta-analysis

Keywords: CD3×CD20 bispecific antibodies (BsAbs), chimeric antigen receptor T-cell (CAR-T) , large B-cell lymphoma (LBCL), salvage therapy.

Review Status: ongoing